A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Study Title This is a randomized, multicenter, placebo-controlled, double-blind, phase III clinical trial to evaluate the efficacy of Fampridine in Multiple Sclerosis (MS). Study Objectives The primary objective of the study is to evaluate the efficacy and safety of extended-release Fampridine in the treatment of motor dysfunction in adult patients with multiple sclerosis. Primary Endpoint The proportion of patients who experience a steady improvement in walk speed during treatment, as will bedoi:10.26253/heal.uth.7371 fatcat:elkjazfivra3nlgx4tazupoyla